453
H. Ge et al.
Paper
Synthesis
ESI-MS: m/z = 821.3 [2 M + Na]+.
Diisopropyl (E)-[2-(1,3-Dioxoisoindolin-2-yl)prop-1-en-1-yl]phos-
phonate (2k)
Diethyl (E)-[2,6-Bis(1,3-dioxoisoindolin-2-yl)hex-1-en-1-yl]phos-
Yield: 0.092 g (94%); light yellow oil.
phonate (2e)
1H NMR (400 MHz, CDCl3): δ = 7.88–7.84 (m, 2 H, Ph), 7.78–7.74 (m, 2
H, Ph), 5.75 (d, J = 10.4 Hz, 1 H, CH), 4.92–4.48 (m, 2 H, 2 × OCH), 2.49
(s, 3 H, CH3), 1.35 (d, J = 5.7 Hz, 12 H, 4 × CH3).
13C NMR (101 MHz, CDCl3): δ = 166.16 (C=O), 145.80 (d, J = 19.4 Hz,
C–N), 134.61, 131.47, 123.77 (Ph), 117.15 (d, J = 188.4 Hz, C–P), 70.78
(d, J = 5.4 Hz, OCH), 24.05 (d, J = 4.2 Hz, CH3), 23.86 (d, J = 4.4 Hz, CH3),
18.81 (d, J = 3.7 Hz, CH3).
Yield: 0.114 g (80%); light yellow oil.
1H NMR (400 MHz, CDCl3): δ = 7.80–7.76 (m, 2 H, Ph), 7.72–7.69 (m, 2
H, Ph), 7.68–7.65 (m, 2 H, Ph), 7.61–7.58 (m, 2 H, Ph), 5.62 (d, J = 10.6
Hz, 1 H, CH), 4.16–4.03 (m, 4 H, 2 × OCH2), 3.55 (t, J = 7.0 Hz, 2 H, CH2),
3.05 (t, J = 6.7 Hz, 2 H, CH2), 1.71–1.61 (m, 2 H, CH2), 1.43–1.33 (m, 2
H, CH2), 1.29 (t, J = 7.0 Hz, 6 H, 2 × CH3).
13C NMR (101 MHz, CDCl3): δ = 168.23 (C=O), 166.35 (C=O), 150.26 (d,
J = 20.0 Hz, C–N), 134.58, 133.76, 132.08, 131.39, 123.86, 123.09 (Ph),
116.89 (d, J = 188.3 Hz, C–P), 62.12 (d, J = 5.5 Hz, OCH2), 37.52 (CH2),
30.51 (d, J = 3.6 Hz, CH2), 27.94 (CH2), 24.60 (d, J = 1.3 Hz, CH2), 16.32
(d, J = 6.5 Hz, CH3).
31P NMR (162 MHz, CDCl3): δ = 14.70 (s).
ESI-MS: m/z = 533.4 [M + Na]+.
31P NMR (162 MHz, CDCl3): δ = 12.97 (s).
ESI-MS: m/z = 374.2 [M + Na]+.
Dibutyl (E)-[2-(1,3-Dioxoisoindolin-2-yl)prop-1-en-1-yl]phospho-
nate (2l)
Yield: 0.086 g (81%); light yellow oil.
1H NMR (400 MHz, CDCl3): δ = 7.93–7.87 (m, 2 H, Ph), 7.82–7.77 (m, 2
H, Ph), 5.78 (d, J = 10.5 Hz, 1 H, CH), 4.10 (q, J = 6.7 Hz, 4 H, 2 × OCH2),
2.53 (d, J = 2.7 Hz, 3 H, CH3), 1.86–1.63 (m, 4 H, 2 × CH2), 1.55–1.35
(m, 4 H, 2 × CH2), 0.95 (t, J = 7.4 Hz, 6 H, 2 × CH3).
Diethyl (E)-[2-(1,3-Dioxoisoindolin-2-yl)but-1-en-1-yl]phospho-
nate (2h)
Yield: 0.053 g (56%); light yellow oil.
13C NMR (101 MHz, CDCl3): δ = 166.10 (C=O), 146.65 (d, J = 19.8 Hz,
C–N), 134.65, 131.45, 123.83 (Ph), 115.09 (d, J = 188.8 Hz, C–P), 65.67
(d, J = 5.5 Hz, OCH2), 32.42 (d, J = 6.6 Hz, CH2), 18.90 (d, J = 3.6 Hz,
CH3), 18.78 (CH2), 13.62 (CH3).
31P NMR (162 MHz, CDCl3): δ = 15.65 (s).
ESI-MS: m/z = 402.2 [M + Na]+.
1H NMR (400 MHz, CDCl3): δ = 7.98–7.83 (m, 2 H, Ph), 7.82–7.73 (m, 2
H, Ph), 5.63 (d, J = 10.8 Hz, 1 H, CH), 4.22–4.09 (m, 4 H, 2 × OCH2), 3.08
(dd, J = 13.9, 6.4 Hz, 2 H, CH2), 1.35 (t, J = 7.0 Hz, 6 H, 2 × CH3), 0.99 (t,
J = 7.4 Hz, 3 H, CH3).
13C NMR (101 MHz, CDCl3): δ = 166.45 (C=O), 152.01 (d, J = 17.4 Hz,
C–N), 134.66, 131.39, 123.88 (Ph), 115.72 (d, J = 187.7 Hz, C–P), 62.03
(d, J = 5.2 Hz, OCH2), 29.71 (CH2), 24.54 (d, J = 3.6 Hz, CH3), 16.34 (d,
J = 6.6 Hz, CH3).
Diisopropyl (E)-[2-(1,3-Dioxoisoindolin-2-yl)-3-phenylprop-1-en-
1-yl]phosphonate (2m)
31P NMR (162 MHz, CDCl3): δ = 14.96 (s).
ESI-MS: m/z = 338.2 [M + H]+.
Yield: 0.072 g (60%); light yellow oil.
1H NMR (400 MHz, CDCl3): δ = 7.86–7.74 (m, 2 H, Ph), 7.72–7.66 (m, 2
H, Ph), 7.23–7.06 (m, 5 H, Ph), 5.81 (d, J = 9.9 Hz, 1 H, CH), 4.87–4.74
(m, 2 H, 2 × OCH), 4.54 (d, J = 2.1 Hz, 2 H, CH2), 1.40 (d, J = 6.2 Hz, 12
H, 4 × CH3).
Diethyl (E)-[2-(1,3-Dioxoisoindolin-2-yl)-2-phenylvinyl]phospho-
nate (2i)
Yield: 0.086 g (80%); colorless oil.
13C NMR (101 MHz, CDCl3): δ = 166.28 (C=O), 147.52 (d, J = 19.7 Hz,
C–N), 136.48, 134.47, 131.14, 128.88, 128.41, 126.66, 123.72 (Ph),
118.69 (d, J = 188.8 Hz, C–P), 71.08 (d, J = 5.5 Hz, OCH), 36.35 (d,
J = 3.6 Hz, CH2), 24.13 (d, J = 4.3 Hz, CH3), 24.00 (d, J = 4.6 Hz, CH3).
31P NMR (162 MHz, CDCl3): δ = 12.44 (s).
ESI-MS: m/z = 450.2 [M + Na]+.
1H NMR (400 MHz, CDCl3): δ = 7.94–7.90 (m, 2 H, Ph), 7.83–7.79 (m, 2
H, Ph), 7.61–7.57 (m, 2 H, Ph), 7.45–7.39 (m, 3 H, Ph), 6.04 (d, J = 9.7
Hz, 1 H, CH), 4.06–3.93 (m, 4 H, 2 × OCH2), 1.18 (t, J = 7.1 Hz, 6 H,
2 × CH3).
13C NMR (101 MHz, CDCl3): δ = 166.07 (C=O), 145.58 (d, J = 16.4 Hz,
C–N), 134.72, 131.53, 130.05, 128.68, 128.13, 124.04 (Ph), 117.24 (d,
J = 190.5 Hz, C–P), 62.13 (d, J = 6.0 Hz, OCH2), 16.08 (d, J = 6.7 Hz, CH3).
Dibutyl (E)-[2-(1,3-Dioxoisoindolin-2-yl)-3-phenylprop-1-en-1-
yl]phosphonate (2n)
31P NMR (162 MHz, CDCl3): δ = 13.54 (s).
ESI-MS: m/z = 408.2 [M + Na]+.
Yield: 0.093 g (73%); light yellow oil.
1H NMR (400 MHz, CDCl3): δ = 7.82–7.76 (m, 2 H, Ph), 7.73–7.68 (m, 2
H, Ph), 7.25–7.06 (m, 5 H, Ph), 5.83 (d, J = 10.2 Hz, 1 H, CH), 4.54 (d,
J = 1.6 Hz, 2 H, CH2), 4.16 (q, J = 6.7 Hz, 4 H, 2 × OCH2), 1.80–1.68 (m, 4
H, 2 × CH2), 1.51–1.42 (m, 4 H, 2 × CH2), 0.96 (t, J = 7.4 Hz, 6 H,
2 × CH3).
13C NMR (101 MHz, CDCl3): δ = 166.18 (C=O), 148.40 (d, J = 19.6 Hz,
C–N), 136.28, 134.53, 131.07, 128.81, 128.45, 126.72, 123.77 (Ph),
116.79 (d, J = 189.3 Hz, C–P), 65.90 (d, J = 6.1 Hz, OCH2), 36.47 (d,
J = 3.6 Hz, CH2), 32.46 (d, J = 6.7 Hz, CH2), 18.81 (CH2), 13.65 (CH3).
Dimethyl (E)-[2-(1,3-Dioxoisoindolin-2-yl)prop-1-en-1-yl]phos-
phonate (2j)
Yield: 0.069 g (84%); light yellow oil.
1H NMR (400 MHz, CDCl3): δ = 7.91–7.86 (m, 2 H, Ph), 7.81–7.76 (m, 2
H, Ph), 5.73 (d, J = 10.8 Hz, 1 H, CH), 3.79 (d, J = 11.3 Hz, 6 H,
2 × OCH3), 2.51 (d, J = 2.7 Hz, 3 H, CH3).
13C NMR (101 MHz, CDCl3): δ = 165.02 (C=O), 146.60 (d, J = 19.7 Hz,
C–N), 133.72, 130.37, 122.87 (Ph), 112.32 (d, J = 190.1 Hz, C–P), 51.43
(d, J = 5.5 Hz, OCH3), 17.90 (d, J = 3.9 Hz, CH3).
31P NMR (162 MHz, CDCl3): δ = 15.03 (s).
ESI-MS: m/z = 478.4 [M + Na]+.
31P NMR (162 MHz, CDCl3): δ = 18.56 (s).
ESI-MS: m/z = 318.4 [M + Na]+.
© Georg Thieme Verlag Stuttgart · New York — Synthesis 2016, 48, 448–454